start_structures/Ligand_Substrate/Ligand_Complex_Stripped/CD7_6B1Y.pdb
 OpenBabel08222315203D

 26 27  0  0  1  0  0  0  0  0999 V2000
    6.3820    1.9830   -3.1150 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.9090    0.6380   -3.3880 C   0  0  2  0  0  0  0  0  0  0  0  0
    4.4980    0.2890   -2.9480 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9840   -0.7480   -3.3640 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.7730   -0.4040   -2.6880 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0590   -0.5150   -3.2680 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.8770    1.1280   -2.1800 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.1480    0.0750   -2.7710 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4060   -0.3340   -3.0160 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.6500   -1.6850   -3.5770 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6140   -2.2300   -2.6400 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6490   -3.5260   -2.4040 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.5490   -1.4980   -1.8760 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.1520   -0.1180   -1.5750 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5090    0.5870   -2.7830 C   0  0  1  0  0  0  0  0  0  0  0  0
   12.3650    0.8500   -3.9130 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9660    0.6560   -5.0760 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.6000    1.3680   -3.6150 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.3100    1.9050   -4.6040 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.0310    3.1670   -4.9880 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.0160    3.7390   -4.6330 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.0830    3.8300   -5.9110 C   0  0  2  0  0  0  0  0  0  0  0  0
   16.3180    4.1570   -5.1770 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8050    5.4370   -4.3580 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7120    6.0610   -5.2050 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.6450    5.2090   -6.4090 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  1  0  0  0
  2  3  1  0  0  0  0
  2  5  1  0  0  0  0
  4  3  2  0  0  0  0
  6  8  1  0  0  0  0
  6  5  1  0  0  0  0
  7  8  2  0  0  0  0
  8  9  1  0  0  0  0
  9 10  1  0  0  0  0
  9 15  1  0  0  0  0
 10 11  1  0  0  0  0
 11 12  2  0  0  0  0
 11 13  1  0  0  0  0
 13 14  1  0  0  0  0
 14 15  1  0  0  0  0
 15 16  1  6  0  0  0
 16 17  2  0  0  0  0
 16 18  1  0  0  0  0
 18 19  1  0  0  0  0
 19 20  1  0  0  0  0
 20 21  2  0  0  0  0
 22 20  1  1  0  0  0
 22 23  1  0  0  0  0
 22 26  1  0  0  0  0
 23 24  1  0  0  0  0
 24 25  1  0  0  0  0
 25 26  1  0  0  0  0
M  END
>  <HEADER>
    HYDROLASE/HYDROLASE INHIBITOR           19-SEP-17   6B1Y              

>  <TITLE>
    CRYSTAL STRUCTURE KPC-2 BETA-LACTAMASE COMPLEXED WITH WCK 5153 BY CO- 
   2 CRYSTALLIZATION                                                      

>  <COMPND>
    MOL_ID: 1;                                                            
   2 MOLECULE: CARBAPENEM-HYDROLYZING BETA-LACTAMASE KPC;                 
   3 CHAIN: A, B;                                                         
   4 SYNONYM: CARBAPENEM-HYDROLYZING BETA-LACTAMASE KPC-1;                
   5 EC: 3.5.2.6;                                                         
   6 ENGINEERED: YES                                                      

>  <SOURCE>
    MOL_ID: 1;                                                            
   2 ORGANISM_SCIENTIFIC: KLEBSIELLA PNEUMONIAE;                          
   3 ORGANISM_TAXID: 573;                                                 
   4 GENE: BLA, KPC, KPC1;                                                
   5 EXPRESSION_SYSTEM: ESCHERICHIA COLI;                                 
   6 EXPRESSION_SYSTEM_TAXID: 562                                         

>  <KEYWDS>
    INHIBITOR, COMPLEX, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX  

>  <EXPDTA>
    X-RAY DIFFRACTION                                                     

>  <AUTHOR>
    F.VAN DEN AKKER,N.Q.NGUYEN                                            

>  <REVDAT>
   1   01-AUG-18 6B1Y    0                                                

>  <JRNL>
      AUTH   K.M.PAPP-WALLACE,N.Q.NGUYEN,M.R.JACOBS,C.R.BETHEL,           
      AUTH 2 M.D.BARNES,V.KUMAR,S.BAJAKSOUZIAN,S.D.RUDIN,P.N.RATHER,      
      AUTH 3 S.BHAVSAR,T.RAVIKUMAR,P.K.DESHPANDE,V.PATIL,R.YEOLE,         
      AUTH 4 S.S.BHAGWAT,M.V.PATEL,F.VAN DEN AKKER,R.A.BONOMO             
      TITL   STRATEGIC APPROACHES TO OVERCOME RESISTANCE AGAINST          
      TITL 2 GRAM-NEGATIVE PATHOGENS USING BETA-LACTAMASE INHIBITORS AND  
      TITL 3 BETA-LACTAM ENHANCERS: ACTIVITY OF THREE NOVEL               
      TITL 4 DIAZABICYCLOOCTANES WCK 5153, ZIDEBACTAM (WCK 5107), AND WCK 
      TITL 5 4234.                                                        
      REF    J. MED. CHEM.                 V.  61  4067 2018              
      REFN                   ISSN 1520-4804                               
      PMID   29627985                                                     
      DOI    10.1021/ACS.JMEDCHEM.8B00091                                 

>  <REMARK>
   2                                                                      
   2 RESOLUTION.    1.80 ANGSTROMS.                                       
   3                                                                      
   3 REFINEMENT.                                                          
   3   PROGRAM     : REFMAC 5.8.0135                                      
   3   AUTHORS     : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER,              
   3               : NICHOLLS,WINN,LONG,VAGIN                             
   3                                                                      
   3    REFINEMENT TARGET : NULL                                          
   3                                                                      
   3  DATA USED IN REFINEMENT.                                            
   3   RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80                           
   3   RESOLUTION RANGE LOW  (ANGSTROMS) : 37.13                          
   3   DATA CUTOFF            (SIGMA(F)) : 0.000                          
   3   COMPLETENESS FOR RANGE        (%) : 95.5                           
   3   NUMBER OF REFLECTIONS             : 34166                          
   3                                                                      
   3  FIT TO DATA USED IN REFINEMENT.                                     
   3   CROSS-VALIDATION METHOD          : THROUGHOUT                      
   3   FREE R VALUE TEST SET SELECTION  : RANDOM                          
   3   R VALUE     (WORKING + TEST SET) : 0.151                           
   3   R VALUE            (WORKING SET) : 0.149                           
   3   FREE R VALUE                     : 0.197                           
   3   FREE R VALUE TEST SET SIZE   (%) : 5.000                           
   3   FREE R VALUE TEST SET COUNT      : 1799                            
   3                                                                      
   3  FIT IN THE HIGHEST RESOLUTION BIN.                                  
   3   TOTAL NUMBER OF BINS USED           : 20                           
   3   BIN RESOLUTION RANGE HIGH       (A) : 1.80                         
   3   BIN RESOLUTION RANGE LOW        (A) : 1.85                         
   3   REFLECTION IN BIN     (WORKING SET) : 2461                         
   3   BIN COMPLETENESS (WORKING+TEST) (%) : 92.42                        
   3   BIN R VALUE           (WORKING SET) : 0.2190                       
   3   BIN FREE R VALUE SET COUNT          : 137                          
   3   BIN FREE R VALUE                    : 0.2980                       
   3                                                                      
   3  NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.                    
   3   PROTEIN ATOMS            : 3975                                    
   3   NUCLEIC ACID ATOMS       : 0                                       
   3   HETEROGEN ATOMS          : 77                                      
   3   SOLVENT ATOMS            : 335                                     
   3                                                                      
   3  B VALUES.                                                           
   3   FROM WILSON PLOT           (A**2) : NULL                           
   3   MEAN B VALUE      (OVERALL, A**2) : 14.15                          
   3   OVERALL ANISOTROPIC B VALUE.                                       
   3    B11 (A**2) : 0.02000                                              
   3    B22 (A**2) : -0.01000                                             
   3    B33 (A**2) : -0.01000                                             
   3    B12 (A**2) : 0.01000                                              
   3    B13 (A**2) : -0.01000                                             
   3    B23 (A**2) : 0.00000                                              
   3                                                                      
   3  ESTIMATED OVERALL COORDINATE ERROR.                                 
   3   ESU BASED ON R VALUE                            (A): 0.142         
   3   ESU BASED ON FREE R VALUE                       (A): 0.131         
   3   ESU BASED ON MAXIMUM LIKELIHOOD                 (A): 0.088         
   3   ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.860         
   3                                                                      
   3 CORRELATION COEFFICIENTS.                                            
   3   CORRELATION COEFFICIENT FO-FC      : 0.962                         
   3   CORRELATION COEFFICIENT FO-FC FREE : 0.926                         
   3                                                                      
   3  RMS DEVIATIONS FROM IDEAL VALUES        COUNT    RMS    WEIGHT      
   3   BOND LENGTHS REFINED ATOMS        (A):  4133 ; 0.015 ; 0.020       
   3   BOND LENGTHS OTHERS               (A):  3913 ; 0.003 ; 0.020       
   3   BOND ANGLES REFINED ATOMS   (DEGREES):  5632 ; 1.694 ; 1.975       
   3   BOND ANGLES OTHERS          (DEGREES):  8973 ; 1.097 ; 3.005       
   3   TORSION ANGLES, PERIOD 1    (DEGREES):   531 ; 6.369 ; 5.000       
   3   TORSION ANGLES, PERIOD 2    (DEGREES):   164 ;36.202 ;23.537       
   3   TORSION ANGLES, PERIOD 3    (DEGREES):   623 ;13.920 ;15.000       
   3   TORSION ANGLES, PERIOD 4    (DEGREES):    30 ;16.043 ;15.000       
   3   CHIRAL-CENTER RESTRAINTS       (A**3):   647 ; 0.114 ; 0.200       
   3   GENERAL PLANES REFINED ATOMS      (A):  4715 ; 0.009 ; 0.021       
   3   GENERAL PLANES OTHERS             (A):   925 ; 0.005 ; 0.020       
   3   NON-BONDED CONTACTS REFINED ATOMS (A):  NULL ;  NULL ;  NULL       
   3   NON-BONDED CONTACTS OTHERS        (A):  NULL ;  NULL ;  NULL       
   3   NON-BONDED TORSION REFINED ATOMS  (A):  NULL ;  NULL ;  NULL       
   3   NON-BONDED TORSION OTHERS         (A):  NULL ;  NULL ;  NULL       
   3   H-BOND (X...Y) REFINED ATOMS      (A):  NULL ;  NULL ;  NULL       
   3   H-BOND (X...Y) OTHERS             (A):  NULL ;  NULL ;  NULL       
   3   POTENTIAL METAL-ION REFINED ATOMS (A):  NULL ;  NULL ;  NULL       
   3   POTENTIAL METAL-ION OTHERS        (A):  NULL ;  NULL ;  NULL       
   3   SYMMETRY VDW REFINED ATOMS        (A):  NULL ;  NULL ;  NULL       
   3   SYMMETRY VDW OTHERS               (A):  NULL ;  NULL ;  NULL       
   3   SYMMETRY H-BOND REFINED ATOMS     (A):  NULL ;  NULL ;  NULL       
   3   SYMMETRY H-BOND OTHERS            (A):  NULL ;  NULL ;  NULL       
   3   SYMMETRY METAL-ION REFINED ATOMS  (A):  NULL ;  NULL ;  NULL       
   3   SYMMETRY METAL-ION OTHERS         (A):  NULL ;  NULL ;  NULL       
   3                                                                      
   3  ISOTROPIC THERMAL FACTOR RESTRAINTS.     COUNT   RMS    WEIGHT      
   3   MAIN-CHAIN BOND REFINED ATOMS  (A**2):  NULL ;  NULL ;  NULL       
   3   MAIN-CHAIN BOND OTHER ATOMS    (A**2):  NULL ;  NULL ;  NULL       
   3   MAIN-CHAIN ANGLE REFINED ATOMS (A**2):  NULL ;  NULL ;  NULL       
   3   MAIN-CHAIN ANGLE OTHER ATOMS   (A**2):  NULL ;  NULL ;  NULL       
   3   SIDE-CHAIN BOND REFINED ATOMS  (A**2):  NULL ;  NULL ;  NULL       
   3   SIDE-CHAIN BOND OTHER ATOMS    (A**2):  NULL ;  NULL ;  NULL       
   3   SIDE-CHAIN ANGLE REFINED ATOMS (A**2):  NULL ;  NULL ;  NULL       
   3   SIDE-CHAIN ANGLE OTHER ATOMS   (A**2):  NULL ;  NULL ;  NULL       
   3   LONG RANGE B REFINED ATOMS     (A**2):  NULL ;  NULL ;  NULL       
   3   LONG RANGE B OTHER ATOMS       (A**2):  NULL ;  NULL ;  NULL       
   3                                                                      
   3 ANISOTROPIC THERMAL FACTOR RESTRAINTS.    COUNT   RMS   WEIGHT       
   3   RIGID-BOND RESTRAINTS          (A**2):  NULL ;  NULL ;  NULL       
   3   SPHERICITY; FREE ATOMS         (A**2):  NULL ;  NULL ;  NULL       
   3   SPHERICITY; BONDED ATOMS       (A**2):  NULL ;  NULL ;  NULL       
   3                                                                      
   3  NCS RESTRAINTS STATISTICS                                           
   3   NUMBER OF DIFFERENT NCS GROUPS : NULL                              
   3                                                                      
   3  TLS DETAILS                                                         
   3   NUMBER OF TLS GROUPS  : NULL                                       
   3                                                                      
   3  BULK SOLVENT MODELLING.                                             
   3   METHOD USED : NULL                                                 
   3   PARAMETERS FOR MASK CALCULATION                                    
   3   VDW PROBE RADIUS   : 1.20                                          
   3   ION PROBE RADIUS   : 0.80                                          
   3   SHRINKAGE RADIUS   : 0.80                                          
   3                                                                      
   3  OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING   
   3  POSITIONS U VALUES : REFINED INDIVIDUALLY                           
   4                                                                      
   4 6B1Y COMPLIES WITH FORMAT V. 3.30, 13-JUL-11                         
 100                                                                      
 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 20-SEP-17.                  
 100 THE DEPOSITION ID IS D_1000230152.                                   
 200                                                                      
 200 EXPERIMENTAL DETAILS                                                 
 200  EXPERIMENT TYPE                : X-RAY DIFFRACTION                  
 200  DATE OF DATA COLLECTION        : 17-MAY-15                          
 200  TEMPERATURE           (KELVIN) : 100                                
 200  PH                             : 4.4 - 4.6                          
 200  NUMBER OF CRYSTALS USED        : 1                                  
 200                                                                      
 200  SYNCHROTRON              (Y/N) : Y                                  
 200  RADIATION SOURCE               : SSRL                               
 200  BEAMLINE                       : BL7-1                              
 200  X-RAY GENERATOR MODEL          : NULL                               
 200  MONOCHROMATIC OR LAUE    (M/L) : M                                  
 200  WAVELENGTH OR RANGE        (A) : 1.12708                            
 200  MONOCHROMATOR                  : NULL                               
 200  OPTICS                         : NULL                               
 200                                                                      
 200  DETECTOR TYPE                  : CCD                                
 200  DETECTOR MANUFACTURER          : ADSC QUANTUM 315R                  
 200  INTENSITY-INTEGRATION SOFTWARE : XDS                                
 200  DATA SCALING SOFTWARE          : AIMLESS 0.5.8                      
 200                                                                      
 200  NUMBER OF UNIQUE REFLECTIONS   : 35965                              
 200  RESOLUTION RANGE HIGH      (A) : 1.800                              
 200  RESOLUTION RANGE LOW       (A) : 37.130                             
 200  REJECTION CRITERIA  (SIGMA(I)) : NULL                               
 200                                                                      
 200 OVERALL.                                                             
 200  COMPLETENESS FOR RANGE     (%) : 95.5                               
 200  DATA REDUNDANCY                : 2.000                              
 200  R MERGE                    (I) : 0.04600                            
 200  R SYM                      (I) : NULL                               
 200  <I/SIGMA(I)> FOR THE DATA SET  : 14.0000                            
 200                                                                      
 200 IN THE HIGHEST RESOLUTION SHELL.                                     
 200  HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80                     
 200  HIGHEST RESOLUTION SHELL, RANGE LOW  (A) : 1.84                     
 200  COMPLETENESS FOR SHELL     (%) : 92.0                               
 200  DATA REDUNDANCY IN SHELL       : 2.00                               
 200  R MERGE FOR SHELL          (I) : 0.27200                            
 200  R SYM FOR SHELL            (I) : NULL                               
 200  <I/SIGMA(I)> FOR SHELL         : NULL                               
 200                                                                      
 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH                              
 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT        
 200 SOFTWARE USED: NULL                                                  
 200 STARTING MODEL: NULL                                                 
 200                                                                      
 200 REMARK: NULL                                                         
 280                                                                      
 280 CRYSTAL                                                              
 280 SOLVENT CONTENT, VS   (%): 33.73                                     
 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.86                     
 280                                                                      
 280 CRYSTALLIZATION CONDITIONS: 200MM LITHIUM SULFATE, 100MM SODIUM      
 280  ACETATE PH 4.4-4.6, AND 28-31% PEG8000. PROTEIN TO INHIBITOR        
 280  MOLAR RATIO OF 1 IS TO 10 AND KPC-2 CONCENTRATION WAS 10 MG/ML,     
 280  VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 295K                     
 290                                                                      
 290 CRYSTALLOGRAPHIC SYMMETRY                                            
 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1                              
 290                                                                      
 290      SYMOP   SYMMETRY                                                
 290     NNNMMM   OPERATOR                                                
 290       1555   X,Y,Z                                                   
 290                                                                      
 290     WHERE NNN -> OPERATOR NUMBER                                     
 290           MMM -> TRANSLATION VECTOR                                  
 290                                                                      
 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS                            
 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM             
 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY                
 290 RELATED MOLECULES.                                                   
 290   SMTRY1   1  1.000000  0.000000  0.000000        0.00000            
 290   SMTRY2   1  0.000000  1.000000  0.000000        0.00000            
 290   SMTRY3   1  0.000000  0.000000  1.000000        0.00000            
 290                                                                      
 290 REMARK: NULL                                                         
 300                                                                      
 300 BIOMOLECULE: 1, 2                                                    
 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM                
 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN                  
 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON               
 300 BURIED SURFACE AREA.                                                 
 350                                                                      
 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN           
 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE                
 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS          
 350 GIVEN BELOW.  BOTH NON-CRYSTALLOGRAPHIC AND                          
 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.                               
 350                                                                      
 350 BIOMOLECULE: 1                                                       
 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC                         
 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC                  
 350 SOFTWARE USED: PISA                                                  
 350 APPLY THE FOLLOWING TO CHAINS: A                                     
 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000            
 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000            
 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000            
 350                                                                      
 350 BIOMOLECULE: 2                                                       
 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC                         
 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC                  
 350 SOFTWARE USED: PISA                                                  
 350 APPLY THE FOLLOWING TO CHAINS: B                                     
 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000            
 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000            
 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000            
 465                                                                      
 465 MISSING RESIDUES                                                     
 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE                       
 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN               
 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)                
 465                                                                      
 465   M RES C SSSEQI                                                     
 465     ALA B    22                                                      
 465     THR B    23                                                      
 465     ALA B    24                                                      
 500                                                                      
 500 GEOMETRY AND STEREOCHEMISTRY                                         
 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT                     
 500                                                                      
 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT.                            
 500                                                                      
 500  ATM1  RES C  SSEQI   ATM2  RES C  SSEQI           DISTANCE          
 500   O2   SO4 B   306     O    HOH B   401              1.99            
 500   OG   SER A    70     OAB  CD7 A   301              2.13            
 500   OG   SER B    70     OAB  CD7 B   301              2.17            
 500                                                                      
 500 REMARK: NULL                                                         
 500                                                                      
 500 GEOMETRY AND STEREOCHEMISTRY                                         
 500 SUBTOPIC: CLOSE CONTACTS                                             
 500                                                                      
 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC             
 500 SYMMETRY ARE IN CLOSE CONTACT.  AN ATOM LOCATED WITHIN 0.15          
 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A           
 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375             
 500 INSTEAD OF REMARK 500.  ATOMS WITH NON-BLANK ALTERNATE               
 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS.            
 500                                                                      
 500 DISTANCE CUTOFF:                                                     
 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS              
 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS                  
 500                                                                      
 500  ATM1  RES C  SSEQI   ATM2  RES C  SSEQI  SSYMOP   DISTANCE          
 500   OD2  ASP A    92     NH1  ARG A   161     1545     2.01            
 500                                                                      
 500 REMARK: NULL                                                         
 500                                                                      
 500 GEOMETRY AND STEREOCHEMISTRY                                         
 500 SUBTOPIC: COVALENT BOND ANGLES                                       
 500                                                                      
 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES              
 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE               
 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN               
 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).                 
 500                                                                      
 500 STANDARD TABLE:                                                      
 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1)              
 500                                                                      
 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999                        
 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996                     
 500                                                                      
 500  M RES CSSEQI ATM1   ATM2   ATM3                                     
 500    ARG B 178   NE  -  CZ  -  NH1 ANGL. DEV. =   3.0 DEGREES          
 500    ARG B 204   NE  -  CZ  -  NH1 ANGL. DEV. =   3.3 DEGREES          
 500                                                                      
 500 REMARK: NULL                                                         
 500                                                                      
 500 GEOMETRY AND STEREOCHEMISTRY                                         
 500 SUBTOPIC: TORSION ANGLES                                             
 500                                                                      
 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:            
 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;               
 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).                             
 500                                                                      
 500 STANDARD TABLE:                                                      
 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)                    
 500                                                                      
 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-           
 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400            
 500                                                                      
 500  M RES CSSEQI        PSI       PHI                                   
 500    CYS A  69     -139.16     51.49                                   
 500    SER A 197       30.24    -98.84                                   
 500    ARG A 220     -124.21   -111.03                                   
 500    CYS B  69     -138.36     46.57                                   
 500    GLN B  87       79.79   -162.72                                   
 500    ARG B 220     -121.66   -113.20                                   
 500                                                                      
 500 REMARK: NULL                                                         
 600                                                                      
 600 HETEROGEN                                                            
 600                                                                      
 600 THE COVALENTLY BOUND INHIBITOR BECOMES DESULFATED DURING THE CO-     
 600 CRYSTALLIZATION PROCESS                                              
 610                                                                      
 610 MISSING HETEROATOM                                                   
 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER;           
 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER;          
 610 I=INSERTION CODE):                                                   
 610   M RES C SSEQI                                                      
 610     CD7 A  301                                                       
 610     CD7 B  301                                                       
 800                                                                      
 800 SITE                                                                 
 800 SITE_IDENTIFIER: AC1                                                 
 800 EVIDENCE_CODE: SOFTWARE                                              
 800 SITE_DESCRIPTION: binding site for residue CD7 A 301                 
 800                                                                      
 800 SITE_IDENTIFIER: AC2                                                 
 800 EVIDENCE_CODE: SOFTWARE                                              
 800 SITE_DESCRIPTION: binding site for residue SO4 A 302                 
 800                                                                      
 800 SITE_IDENTIFIER: AC3                                                 
 800 EVIDENCE_CODE: SOFTWARE                                              
 800 SITE_DESCRIPTION: binding site for residue SO4 A 303                 
 800                                                                      
 800 SITE_IDENTIFIER: AC4                                                 
 800 EVIDENCE_CODE: SOFTWARE                                              
 800 SITE_DESCRIPTION: binding site for residue CL A 304                  
 800                                                                      
 800 SITE_IDENTIFIER: AC5                                                 
 800 EVIDENCE_CODE: SOFTWARE                                              
 800 SITE_DESCRIPTION: binding site for residue SO4 B 302                 
 800                                                                      
 800 SITE_IDENTIFIER: AC6                                                 
 800 EVIDENCE_CODE: SOFTWARE                                              
 800 SITE_DESCRIPTION: binding site for residue SO4 B 303                 
 800                                                                      
 800 SITE_IDENTIFIER: AC7                                                 
 800 EVIDENCE_CODE: SOFTWARE                                              
 800 SITE_DESCRIPTION: binding site for residue SO4 B 304                 
 800                                                                      
 800 SITE_IDENTIFIER: AC8                                                 
 800 EVIDENCE_CODE: SOFTWARE                                              
 800 SITE_DESCRIPTION: binding site for residue SO4 B 305                 
 800                                                                      
 800 SITE_IDENTIFIER: AC9                                                 
 800 EVIDENCE_CODE: SOFTWARE                                              
 800 SITE_DESCRIPTION: binding site for residue SO4 B 306                 
 800                                                                      
 800 SITE_IDENTIFIER: AD1                                                 
 800 EVIDENCE_CODE: SOFTWARE                                              
 800 SITE_DESCRIPTION: binding site for residue CL B 307                  
 800                                                                      
 800 SITE_IDENTIFIER: AD2                                                 
 800 EVIDENCE_CODE: SOFTWARE                                              
 800 SITE_DESCRIPTION: binding site for Di-peptide CD7 B 301 and SER B    
 800  70                                                                  
 900                                                                      
 900 RELATED ENTRIES                                                      
 900 RELATED ID: 6B1X   RELATED DB: PDB                                   
 900 6B1X CONTAINS THE SAME PROTEIN COMPLEX WITH WCK 5153 BUT IS          
 900 OBTAINED BY SOAKING                                                  

>  <DBREF>
 6B1Y A   22   291  UNP    Q9F663   BLKPC_KLEPN     22    289             
 6B1Y B   22   291  UNP    Q9F663   BLKPC_KLEPN     22    289             

>  <SEQRES>
   1 A  268  ALA THR ALA LEU THR ASN LEU VAL ALA GLU PRO PHE ALA          
   2 A  268  LYS LEU GLU GLN ASP PHE GLY GLY SER ILE GLY VAL TYR          
   3 A  268  ALA MET ASP THR GLY SER GLY ALA THR VAL SER TYR ARG          
   4 A  268  ALA GLU GLU ARG PHE PRO LEU CYS SER SER PHE LYS GLY          
   5 A  268  PHE LEU ALA ALA ALA VAL LEU ALA ARG SER GLN GLN GLN          
   6 A  268  ALA GLY LEU LEU ASP THR PRO ILE ARG TYR GLY LYS ASN          
   7 A  268  ALA LEU VAL PRO TRP SER PRO ILE SER GLU LYS TYR LEU          
   8 A  268  THR THR GLY MET THR VAL ALA GLU LEU SER ALA ALA ALA          
   9 A  268  VAL GLN TYR SER ASP ASN ALA ALA ALA ASN LEU LEU LEU          
  10 A  268  LYS GLU LEU GLY GLY PRO ALA GLY LEU THR ALA PHE MET          
  11 A  268  ARG SER ILE GLY ASP THR THR PHE ARG LEU ASP ARG TRP          
  12 A  268  GLU LEU GLU LEU ASN SER ALA ILE PRO GLY ASP ALA ARG          
  13 A  268  ASP THR SER SER PRO ARG ALA VAL THR GLU SER LEU GLN          
  14 A  268  LYS LEU THR LEU GLY SER ALA LEU ALA ALA PRO GLN ARG          
  15 A  268  GLN GLN PHE VAL ASP TRP LEU LYS GLY ASN THR THR GLY          
  16 A  268  ASN HIS ARG ILE ARG ALA ALA VAL PRO ALA ASP TRP ALA          
  17 A  268  VAL GLY ASP LYS THR GLY THR CYS GLY VAL TYR GLY THR          
  18 A  268  ALA ASN ASP TYR ALA VAL VAL TRP PRO THR GLY ARG ALA          
  19 A  268  PRO ILE VAL LEU ALA VAL TYR THR ARG ALA PRO ASN LYS          
  20 A  268  ASP ASP LYS HIS SER GLU ALA VAL ILE ALA ALA ALA ALA          
  21 A  268  ARG LEU ALA LEU GLU GLY LEU GLY                              
   1 B  268  ALA THR ALA LEU THR ASN LEU VAL ALA GLU PRO PHE ALA          
   2 B  268  LYS LEU GLU GLN ASP PHE GLY GLY SER ILE GLY VAL TYR          
   3 B  268  ALA MET ASP THR GLY SER GLY ALA THR VAL SER TYR ARG          
   4 B  268  ALA GLU GLU ARG PHE PRO LEU CYS SER SER PHE LYS GLY          
   5 B  268  PHE LEU ALA ALA ALA VAL LEU ALA ARG SER GLN GLN GLN          
   6 B  268  ALA GLY LEU LEU ASP THR PRO ILE ARG TYR GLY LYS ASN          
   7 B  268  ALA LEU VAL PRO TRP SER PRO ILE SER GLU LYS TYR LEU          
   8 B  268  THR THR GLY MET THR VAL ALA GLU LEU SER ALA ALA ALA          
   9 B  268  VAL GLN TYR SER ASP ASN ALA ALA ALA ASN LEU LEU LEU          
  10 B  268  LYS GLU LEU GLY GLY PRO ALA GLY LEU THR ALA PHE MET          
  11 B  268  ARG SER ILE GLY ASP THR THR PHE ARG LEU ASP ARG TRP          
  12 B  268  GLU LEU GLU LEU ASN SER ALA ILE PRO GLY ASP ALA ARG          
  13 B  268  ASP THR SER SER PRO ARG ALA VAL THR GLU SER LEU GLN          
  14 B  268  LYS LEU THR LEU GLY SER ALA LEU ALA ALA PRO GLN ARG          
  15 B  268  GLN GLN PHE VAL ASP TRP LEU LYS GLY ASN THR THR GLY          
  16 B  268  ASN HIS ARG ILE ARG ALA ALA VAL PRO ALA ASP TRP ALA          
  17 B  268  VAL GLY ASP LYS THR GLY THR CYS GLY VAL TYR GLY THR          
  18 B  268  ALA ASN ASP TYR ALA VAL VAL TRP PRO THR GLY ARG ALA          
  19 B  268  PRO ILE VAL LEU ALA VAL TYR THR ARG ALA PRO ASN LYS          
  20 B  268  ASP ASP LYS HIS SER GLU ALA VAL ILE ALA ALA ALA ALA          
  21 B  268  ARG LEU ALA LEU GLU GLY LEU GLY                              

>  <HET>
 CD7  A 301      20                                                       
 SO4  A 302       5                                                       
 SO4  A 303       5                                                       
  CL  A 304       1                                                       
 CD7  B 301      20                                                       
 SO4  B 302       5                                                       
 SO4  B 303       5                                                       
 SO4  B 304       5                                                       
 SO4  B 305       5                                                       
 SO4  B 306       5                                                       
  CL  B 307       1                                                       

>  <HETNAM>
     CD7 (2S,5Z)-1-FORMYL-5-IMINO-N'-[(3R)-1-(SULFOOXY)                   
   2 CD7  PYRROLIDINE-3-CARBONYL]PIPERIDINE-2-CARBOHYDRAZIDE              
     SO4 SULFATE ION                                                      
      CL CHLORIDE ION                                                     

>  <HETSYN>
     CD7 OPEN FORM - WCK 5153                                             

>  <FORMUL>
   3  CD7    2(C12 H19 N5 O7 S)                                           
   4  SO4    7(O4 S 2-)                                                   
   6   CL    2(CL 1-)                                                     
  14  HOH   *335(H2 O)                                                    

>  <HELIX>
   1 AA1 LEU A   25  GLY A   41  1                                  17    
   2 AA2 SER A   71  GLN A   86  1                                  16    
   3 AA3 GLY A   98  LEU A  102  5                                   5    
   4 AA4 SER A  106  TYR A  112  1                                   7    
   5 AA5 VAL A  119  TYR A  129  1                                  11    
   6 AA6 ASP A  131  LEU A  142  1                                  12    
   7 AA7 GLY A  143  ILE A  155  1                                  13    
   8 AA8 LEU A  167  SER A  171  5                                   5    
   9 AA9 SER A  182  LEU A  195  1                                  14    
  10 AB1 ALA A  200  GLY A  213  1                                  14    
  11 AB2 ARG A  220  VAL A  225  5                                   6    
  12 AB3 SER A  275  GLY A  289  1                                  15    
  13 AB4 THR B   26  GLY B   41  1                                  16    
  14 AB5 SER B   71  GLN B   87  1                                  17    
  15 AB6 GLY B   89  ASP B   92  5                                   4    
  16 AB7 GLY B   98  LEU B  102  5                                   5    
  17 AB8 SER B  106  TYR B  112  1                                   7    
  18 AB9 VAL B  119  SER B  130  1                                  12    
  19 AC1 ASP B  131  LEU B  142  1                                  12    
  20 AC2 GLY B  144  ILE B  155  1                                  12    
  21 AC3 LEU B  167  SER B  171  5                                   5    
  22 AC4 SER B  182  LEU B  195  1                                  14    
  23 AC5 ALA B  200  GLY B  213  1                                  14    
  24 AC6 ARG B  220  VAL B  225  5                                   6    
  25 AC7 SER B  275  GLY B  289  1                                  15    

>  <SHEET>
   1 AA1 5 THR A  56  TYR A  60  0                                        
   2 AA1 5 SER A  43  ASP A  50 -1  N  VAL A  46   O  TYR A  60           
   3 AA1 5 ILE A 259  ARG A 266 -1  O  TYR A 264   N  GLY A  45           
   4 AA1 5 ALA A 244  TRP A 251 -1  N  VAL A 250   O  ILE A 259           
   5 AA1 5 ALA A 230  THR A 237 -1  N  ALA A 230   O  TRP A 251           
   1 AA2 2 PHE A  66  PRO A  67  0                                        
   2 AA2 2 THR A 180  SER A 181 -1  O  SER A 181   N  PHE A  66           
   1 AA3 2 PRO A  94  ILE A  95  0                                        
   2 AA3 2 MET A 117  THR A 118 -1  O  MET A 117   N  ILE A  95           
   1 AA4 5 THR B  56  TYR B  60  0                                        
   2 AA4 5 SER B  43  ASP B  50 -1  N  VAL B  46   O  TYR B  60           
   3 AA4 5 ILE B 259  ARG B 266 -1  O  TYR B 264   N  GLY B  45           
   4 AA4 5 ALA B 244  TRP B 251 -1  N  ASP B 246   O  VAL B 263           
   5 AA4 5 ALA B 230  THR B 237 -1  N  GLY B 236   O  ASN B 245           
   1 AA5 2 PHE B  66  PRO B  67  0                                        
   2 AA5 2 THR B 180  SER B 181 -1  O  SER B 181   N  PHE B  66           
   1 AA6 2 PRO B  94  ILE B  95  0                                        
   2 AA6 2 MET B 117  THR B 118 -1  O  MET B 117   N  ILE B  95           

>  <SSBOND>
   1 CYS A   69    CYS A  238                          1555   1555  2.06  
   2 CYS B   69    CYS B  238                          1555   1555  2.07  

>  <LINK>
       OG  SER A  70                 CAE CD7 A 301     1555   1555  1.34  
       OG  SER B  70                 CAE CD7 B 301     1555   1555  1.36  

>  <CISPEP>
   1 GLU A  166    LEU A  167          0         6.24                     
   2 GLU B  166    LEU B  167          0         3.73                     

>  <SITE>
   1 AC1 17 SER A  70  LYS A  73  TRP A 105  SER A 130                    
   2 AC1 17 ASN A 132  ILE A 155  ASN A 170  SER A 197                    
   3 AC1 17 GLY A 236  THR A 237  CYS A 238  SO4 A 302                    
   4 AC1 17 HOH A 406  HOH A 416  HOH A 474  HOH A 524                    
   5 AC1 17 HOH A 545                                                     
   1 AC2 10 SER A  70  SER A 130  THR A 216  LYS A 234                    
   2 AC2 10 THR A 235  GLY A 236  THR A 237  CD7 A 301                    
   3 AC2 10 HOH A 487  HOH A 501                                          
   1 AC3  5 ARG A  96  ARG A 164  ARG A 178  HOH A 516                    
   2 AC3  5 LYS B 140                                                     
   1 AC4  2 ASN A 100  ARG B 178                                          
   1 AC5  6 LYS A 140  ARG B  96  ARG B 178  HOH B 411                    
   2 AC5  6 HOH B 519  HOH B 528                                          
   1 AC6  4 SER B 275  GLU B 276  ALA B 277  HOH B 465                    
   1 AC7  8 SER B  70  SER B 130  THR B 216  THR B 235                    
   2 AC7  8 GLY B 236  THR B 237  CD7 B 301  HOH B 515                    
   1 AC8  5 LYS B 111  ALA B 200  ALA B 201  TYR B 241                    
   2 AC8  5 LYS B 270                                                     
   1 AC9  5 ARG B  61  LYS B 212  ALA B 230  VAL B 231                    
   2 AC9  5 HOH B 401                                                     
   1 AD1  3 ARG A 178  GLY B  98  ASN B 100                               
   1 AD2 19 LEU B  68  CYS B  69  SER B  71  PHE B  72                    
   2 AD2 19 LYS B  73  TRP B 105  SER B 130  ASN B 132                    
   3 AD2 19 ASN B 170  LYS B 234  THR B 235  GLY B 236                    
   4 AD2 19 THR B 237  CYS B 238  SO4 B 304  HOH B 406                    
   5 AD2 19 HOH B 425  HOH B 506  HOH B 531                               

>  <ORIGX1>
      1.000000  0.000000  0.000000        0.00000                         

>  <ORIGX2>
      0.000000  1.000000  0.000000        0.00000                         

>  <ORIGX3>
      0.000000  0.000000  1.000000        0.00000                         

>  <SCALE1>
      0.028961 -0.002888 -0.000032        0.00000                         

>  <SCALE2>
      0.000000  0.026907 -0.001091        0.00000                         

>  <SCALE3>
      0.000000  0.000000  0.012195        0.00000                         

>  <MASTER>
      383    0   11   25   18    0   26    6 4387    2   81   42          

$$$$
